Get the Stockscreener App
11.62
1.94%
-0.23
After Hours:
11.60
-0.02
-0.17%
Cellebrite Di Ltd stock is traded at $11.62, with a volume of 2.13M.
It is down -1.94% in the last 24 hours and down -21.22% over the past month.
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
See More
Previous Close:
$11.85
Open:
$11.86
24h Volume:
2.13M
Relative Volume:
0.79
Market Cap:
$2.91B
Revenue:
$496.43M
Net Income/Loss:
$71.35M
P/E Ratio:
40.79
EPS:
0.2849
Net Cash Flow:
$151.57M
1W Performance:
+0.00%
1M Performance:
-21.22%
6M Performance:
-13.93%
1Y Performance:
-28.97%
1-Day Range:
$11.40
$11.97
1-Week Range:
$11.40
$12.43
52-Week Range:
$9.58
$19.98
Cellebrite Di Ltd Stock (CLBT) Company Profile
Name
Cellebrite Di Ltd
Sector
Industry
Phone
-
Address
-
Compare CLBT vs MSFT, ORCL, PLTR, CRWD, FTNT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLBT
Cellebrite Di Ltd
|
11.62 | 2.84B | 496.43M | 71.35M | 151.57M | 0.2849 |
MSFT
Microsoft Corp
|
496.82 | 3.57T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
145.75 | 409.23B | 67.36B | 17.31B | -23.69B | 5.8248 |
PLTR
Palantir Technologies Inc
|
169.46 | 418.04B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
203.42 | 193.82B | 5.09B | -24.89M | 1.43B | -0.0471 |
FTNT
Fortinet Inc
|
154.54 | 110.64B | 7.11B | 1.95B | 2.44B | 2.5883 |
Cellebrite Di Ltd Stock (CLBT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-28-24 | Reiterated | Needham | Buy |
| Mar-13-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Feb-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-19-23 | Initiated | Craig Hallum | Buy |
| Aug-12-22 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-24-22 | Initiated | JP Morgan | Overweight |
| Feb-11-22 | Initiated | Deutsche Bank | Buy |
| Dec-02-21 | Initiated | BofA Securities | Buy |
| Oct-21-21 | Initiated | Citigroup | Buy |
View All
Cellebrite Di Ltd Stock (CLBT) Latest News
Cellebrite (CLBT): CEO Shift and Guidance Cuts Contrast With Surging AI and FedRAMP Gains - Yahoo Finance
Kaplan Fox Launches Securities Probe into Cellebrite DI Ltd (CLBT) Following 29% Stock Plunge and CEO Replacement - Kalkine Media
Cellebrite DI Ltd (CLBT) Faces Securities Investigation After 29% Stock Drop and CEO Change - kalkine.ca
Cellebrite Genesis expands to UK & Australia - SourceSecurity.com
Cellebrite shares plunge over 30% after Q2 reve... - Pluang
Cellebrite DI Ltd. (CLBT) Securities Investigation NoticeLevi & Korsinsky - PR Newswire
Cellebrite Genesis AI Solutions Expand Globally | Security News - Security Informed
Cellebrite (CLBT) Q2 2026 Earnings Call Transcript - The Globe and Mail
Kaplan Fox Announces an Investigation Into Cellebrite DI Ltd. (NASDAQ: CLBT) for Potential Securities Law Violations - The Globe and Mail
Cellebrite Genesis for Enterprise Now Generally Available, Regional Availability Expands to More Global Markets - Japan Wire by Kyodo News
Cellebrite’s New CEO Resets 2026 Outlook After Record 2025 and Calls September Shareholder Meeting - The Globe and Mail
Cellebrite expands Genesis AI tool to enterprise market By Investing.com - Investing.com South Africa
Cellebrite faces securities probe after missing revenue targets and sudden CEO change. - Pluang
Cellebrite DI (CLBT) Stock Falls 29% After ARR Miss and CEO Change, Sparking Securities Investigation - kalkine.ca
Cellebrite DI Says Genesis Platform Now Available to Enterprises, Expands Globally - marketscreener.com
Cellebrite Di Ltd Cellebrite Genesis Is Expanding To More Global Markets And Is Now Generally Available For Enterprise Organizations - TradingView
Cellebrite expands Genesis platform to enterprise and new markets - StreetInsider
Cellebrite (CLBT) officer sets 2026 sell-to-cover for 5,673 shares - Stock Titan
Cellebrite (NASDAQ: CLBT) officer plans tax-driven share sale - Stock Titan
Cellebrite Genesis Expands to Global Markets - Intellectia AI
Cellebrite DI Ltd (CLBT) Stock News Today - TradingKey
Cellebrite (CLBT) Quarterly Figures: Profit Per Share Falls Below Its Benchmark in the Latest Reading; Reaction Snapshot: Shares Finish 5.36% Up at the ClosePre-Announcement Alert - Vinanet
Cellebrite Genesis Expands Internationally - Intellectia AI
Voss Capital reports new stake in Cellebrite (NASDAQ: CLBT) - Stock Titan
Cellebrite (NASDAQ: CLBT) lowers 2026 forecast amid vote on CEO equity plan - Stock Titan
Kaplan Fox Alerts Investors of Cellebrite DI Ltd. (NASDAQ: CLBT) to Possible Securities Law Violations - The National Law Review
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Cellebrite DI Ltd. (CLBT) - GlobeNewswire
Cellebrite’s (CLBT) Compounding Track Record Demands Enterprise Software Re-Rating - Yahoo Finance
Cellebrite DI Ltd. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:CLBT) 2026-08-17 - Seeking Alpha
Cellebrite DI (NASDAQ:CLBT) Stock Price Down 6.2% Following Analyst Downgrade - MarketBeat
Why Cellebrite DI (CLBT) Is Down 30.4% After Cutting 2026 Outlook And Announcing CEO Transition - simplywall.st
Cellebrite DI Is Maintained at Buy by DA Davidson - Moomoo
Cellebrite DI Ltd (CLBT) Stock Up 3.1% and Still Undervalued -- GF Score: 84/100 - GuruFocus
Can Cellebrite DI (NASDAQ:CLBT) Regain Market Confidence? - Kalkine Media
Cellebrite (CLBT) Stock Rebounds As ARR Grows But Outlook Cools - simplywall.st
Cellebrite Announces CEO Transition to Shiven Ramji in Planned Succession - The Globe and Mail
Cellebrite DI (NASDAQ:CLBT) Posts Earnings Results, Beats Expectations By $0.06 EPS - MarketBeat
Cellebrite DI (NASDAQ:CLBT) Given New $15.00 Price Target at Lake Street Capital - MarketBeat
CLBT|Cellebrite DI Ltd|Price:11.110|Chg%:+0.310 - TradingKey
Cellebrite Plunges 29% as New CEO Ramji Slashes 2026 Revenue Outlook - finance.biggo.com
Kaplan Fox is Investigating Cellebrite DI Ltd. (NASDAQ: CLBT) for Potential Securities Law Violations - The Globe and Mail
Cellebrite DI (NASDAQ:CLBT) Given New $16.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Legal Tech Roundup: Cellebrite, LexisNexis - Law360
Cellebrite DI (NASDAQ:CLBT) Sees Unusually-High Trading Volume After Strong Earnings - MarketBeat
DA Davidson Has Lowered Expectations for Cellebrite DI (NASDAQ:CLBT) Stock Price - MarketBeat
Cellebrite DI Ltd. (CLBT) Edges Higher on Steady Demand for Digital Intelligence SolutionsIchimoku Cloud - Vinanet
Cellebrite DI (CLBT) Cuts Guidance And Changes CEO, Is The Stock Now Cheap? - Yahoo Finance
CLBT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Cellebrite DI Ltd. - PR Newswire
Cellebrite DI (NASDAQ:CLBT) Given New $12.50 Price Target at Needham & Company LLC - MarketBeat
Needham cuts Cellebrite stock price target on guidance reduction By Investing.com - Investing.com South Africa
Needham cuts Cellebrite stock price target on guidance reduction - Investing.com
Cellebrite Di Ltd Stock (CLBT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cellebrite Di Ltd Stock (CLBT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| GEE DAVID NICHOLAS | Chief Marketing Officer |
Aug 24 '26 |
Sale |
11.36 |
4,323 |
49,111 |
135,281 |
1.12%
5.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):